Gilead expands FDA label for Biktarvy with Phase I pregnant HIV patient data
The expanded approval of Biktarvy was based on the Phase I trial data showing efficacy in pregnant HIV -positive individuals. View article...
Posts
Showing posts matching the search for Gilead expands FDA label for Biktarvy with Phase I pregnant HIV patient data
